In the future, direct evidence from fetal adipose tissue and transplacental studies will be needed to clarify the specific pathways and mechanisms by which CHAF1A influences fetal fat production, thereby providing new insights into the pathogenesis of GDM-related macrosomia. The gene discussed is CHAF1A; the disease is gestational diabetes.